In the present study, activation of the PPARγ pathway in lal−/− MDSCs with its ligand 9-HODE not only impaired their stimulatory effects on in vivo tumor growth and metastasis (Figure 1), but also significantly retarded the ability of these MSDCs to block in vitro tumor cell proliferation and migration (Figure 2). This evidence concerns the gene PPARG and neoplasm.